StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.99−0.88 (-22.74%)

Close on Nov 16, 2026Market cap $111.17MP/E –Yield –

Armata Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Armata Pharmaceuticals's total assets was $84.48M at Sep 30, 2026. For fiscal 2025 it was $76.88M, down 11.1% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $98.36M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$76.88M-11.1%
FY2024Dec 31, 2024$86.44M-12.1%
FY2023Dec 31, 2023$98.36M+2.6%
FY2022Dec 31, 2022$95.83M+37.4%
FY2021Dec 31, 2021$69.77M+76.6%
FY2020Dec 31, 2020$39.52M+55.3%
FY2019Dec 31, 2019$25.45M+75.0%
FY2018Dec 31, 2018$14.55M+30.6%
FY2017Dec 31, 2017$11.14M-38.6%
FY2016Dec 31, 2016$18.15M-42.4%
FY2015Dec 31, 2015$31.49M+10.0%
FY2014Dec 31, 2014$28.62M-30.6%
FY2013Dec 31, 2013$41.21M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$84.48M-5.6%
Q2 FY2026Jun 30, 2026$89.95M+11.3%
Q1 FY2026Mar 31, 2026$69.80M-20.0%
Q4 FY2025Dec 31, 2025$76.88M-11.1%
Q3 FY2025Sep 30, 2025$89.52M-8.9%
Q2 FY2025Jun 30, 2025$80.79M-25.4%
Q1 FY2025Mar 31, 2025$87.25M-27.5%
Q4 FY2024Dec 31, 2024$86.44M-12.1%
Q3 FY2024Sep 30, 2024$98.24M-12.9%
Q2 FY2024Jun 30, 2024$108.31M+7.0%
Q1 FY2024Mar 31, 2024$120.36M+10.6%
Q4 FY2023Dec 31, 2023$98.36M+2.6%
Q3 FY2023Sep 30, 2023$112.76M+21.4%
Q2 FY2023Jun 30, 2023$101.21M+0.2%
Q1 FY2023Mar 31, 2023$108.78M+0.9%
Q4 FY2022Dec 31, 2022$95.83M+37.4%
Q3 FY2022Sep 30, 2022$92.88M+117.7%
Q2 FY2022Jun 30, 2022$100.98M+109.2%
Q1 FY2022Mar 31, 2022$107.77M+103.9%
Q4 FY2021Dec 31, 2021$69.77M+76.6%
Q3 FY2021Sep 30, 2021$42.67M-6.6%
Q2 FY2021Jun 30, 2021$48.28M-2.4%
Q1 FY2021Mar 31, 2021$52.85M+19.8%
Q4 FY2020Dec 31, 2020$39.52M+55.3%
Q3 FY2020Sep 30, 2020$45.68M+55.9%
Q2 FY2020Jun 30, 2020$49.46M+41.7%
Q1 FY2020Mar 31, 2020$44.10M+358.6%
Q4 FY2019Dec 31, 2019$25.45M+75.0%
Q3 FY2019Sep 30, 2019$29.30M+176.0%
Q2 FY2019Jun 30, 2019$34.92M+197.9%
Q1 FY2019Mar 31, 2019$9.62M-33.2%
Q4 FY2018Dec 31, 2018$14.55M+30.6%
Q3 FY2018Sep 30, 2018$10.62M-22.9%
Q2 FY2018Jun 30, 2018$11.72M-22.4%
Q1 FY2018Mar 31, 2018$14.40M+0.7%
Q4 FY2017Dec 31, 2017$11.14M-38.6%
Q3 FY2017Sep 30, 2017$13.78M–
Q2 FY2017Jun 30, 2017$15.11M–
Q1 FY2017Mar 31, 2017$14.30M–
Q4 FY2016Dec 31, 2016$18.15M–

More Armata Pharmaceuticals figures

See a number that looks wrong?